Otilonium bromide: Difference between revisions
(Created page with " {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 408354493 | IUPAC_name = ''N,N''-Diethyl-''N''-methyl-2-(4-[2-(octyloxy)benzamido]benzoyloxy...") |
m (Protected "Otilonium bromide": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 6: | Line 6: | ||
| verifiedrevid = 408354493 | | verifiedrevid = 408354493 | ||
| IUPAC_name = ''N,N''-Diethyl-''N''-methyl-2-(4-[2-(octyloxy)benzamido]benzoyloxy)ethanaminium bromide | | IUPAC_name = ''N,N''-Diethyl-''N''-methyl-2-(4-[2-(octyloxy)benzamido]benzoyloxy)ethanaminium bromide | ||
| image = Otilonium | | image = Otilonium.png | ||
<!--Clinical data--> | <!--Clinical data--> | ||
| Line 54: | Line 54: | ||
| StdInChIKey = VWZPIJGXYWHBOW-UHFFFAOYSA-N | | StdInChIKey = VWZPIJGXYWHBOW-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Otilonium bromide''' is an [[antimuscarinic]]. It is sold under the trade name '''Spasmoctyl 40''', and as '''Doralin''' in Greece. | '''Otilonium bromide''' is an [[antimuscarinic]]. It is sold under the trade name '''Spasmoctyl 40''', and as '''Doralin''' in Greece. | ||
| Line 62: | Line 66: | ||
[[Category:Quaternary ammonium compounds]] | [[Category:Quaternary ammonium compounds]] | ||
[[Category:Phenol ethers]] | [[Category:Phenol ethers]] | ||
[[Category:Benzoates]] | [[Category:Benzoates]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 16:51, 20 August 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C29H43BrN2O4 |
| Molar mass | 563.57 g/mol |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
|
WikiDoc Resources for Otilonium bromide |
|
Articles |
|---|
|
Most recent articles on Otilonium bromide Most cited articles on Otilonium bromide |
|
Media |
|
Powerpoint slides on Otilonium bromide |
|
Evidence Based Medicine |
|
Cochrane Collaboration on Otilonium bromide |
|
Clinical Trials |
|
Ongoing Trials on Otilonium bromide at Clinical Trials.gov Trial results on Otilonium bromide Clinical Trials on Otilonium bromide at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Otilonium bromide NICE Guidance on Otilonium bromide
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Otilonium bromide Discussion groups on Otilonium bromide Patient Handouts on Otilonium bromide Directions to Hospitals Treating Otilonium bromide Risk calculators and risk factors for Otilonium bromide
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Otilonium bromide |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Otilonium bromide is an antimuscarinic. It is sold under the trade name Spasmoctyl 40, and as Doralin in Greece.
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed ChemSpider identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical articles with unknown parameter in Infobox drug
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Muscarinic antagonists
- Quaternary ammonium compounds
- Phenol ethers
- Benzoates
- Drug